Vimarsana
Biggest News Aggregation in the World

Edication Pricing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edication Pricing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edication Pricing Today - Breaking & Trending Today

Analysis-Prices for New US Drugs Rose 35% in 2023, More Than the Previous Year - Vimarsana News

Analysis-Prices for New US Drugs Rose 35% in 2023, More Than the Previous Year

Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare...

Lower Medication Costs Cut Diabetes Complications - Vimarsana News

Lower Medication Costs Cut Diabetes Complications

Reducing out-of-pocket costs in a value-based medication plan may modestly improve short-term health outcomes in commercially insured individuals with diabetes.

Prices Upped for Diabetes, Obesity Drugs and Many Others - Vimarsana News

Prices Upped for Diabetes, Obesity Drugs and Many Others

The monthly price of Ozempic went up 3.5% to almost $970, while the cost of Mounjaro rose 4.5% to almost $1070 a month, according to a new report in The Wall Street Journal.

Drugmakers Set to Raise US Prices on 500 Drugs in January - Vimarsana News

Drugmakers Set to Raise US Prices on 500 Drugs in January

Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed...

US Sets Policy to Seize Patents If Drug Price Deemed Too High - Vimarsana News

US Sets Policy to Seize Patents If Drug Price Deemed Too High

The Biden Administration has announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.